Using Electrical Impedance Tomography to Investigate the Relationship Between Airflow Rate During High-flow Oxygen Therapy and Pressure in Patients With Heart Failure Compared to Non-invasive Ventilation
Conditions: to Assess the Corresponding PEEP Values in NIV With CPAP Under Different Airflow Rates During HFOT in Heart Failure Patients Interventions: Device: Non-invasive ventilation (NIV) or high-flow oxygen therapy (HFOT) using electrical impedance tomography (EIT) Sponsors: National Taiwan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
Conditions: Type 2 Diabetes; Heart Failure, Reduced Ejection Fraction Interventions: Drug: Ketone Monoester (KE) Sponsors: The University of Texas Health Science Center at San Antonio; National Center for Advancing Translational Sciences (NCATS) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
EHR Nudges to Improve Quality of Care in HF
Conditions: Heart Failure With Reduced Ejection Fraction Interventions: Other: Clinical Decision Support Tool Sponsors: Northwestern University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Conduction System Pacing vs Biventricular Pacing in Systolic Dysfunction and Wide QRS: Mortality, Heart Failure Hospitalization or Cardiac Transplant
Conditions: Cardiac Resynchronization Therapy; Heart Failure Interventions: Procedure: Conduction system pacing; Procedure: Biventricular pacing Sponsors: Hospital Clinic of Barcelona; Institut d ' Investigacions Biom èdiques August Pi i Sunyer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart Failure
Conditions: Heart Failure Interventions: Device: ReDS-Guided; Other: Usual care Sponsors: Shanghai Zhongshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Pacertool Early Feasibility Study - Safety and Performance
Conditions: Heart Failure With Reduced Ejection Fraction; Dyssynchrony; Medical Device Performance Interventions: Device: Cardiac catheterization and evoked response to cardiac stimulation Sponsors: Pacertool AS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Biomarkers in Patients With Suspected HFpEF
Conditions: Heart Failure; Obesity; Heart Failure With Preserved Ejection Fraction Interventions: Diagnostic Test: Plasma biomarker levels Sponsors: NHS Greater Glasgow and Clyde; University of Glasgow; Roche Diagnostics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Human Algorithm Interactions for Acute Respiratory Failure Diagnosis
Conditions: Acute Respiratory Failure Interventions: Other: Artificial Intelligence model predictions without explanation; Other: Artificial intelligence model predictions with explanation; Other: AI model biased against heart failure; Other: AI model biased against pneumonia; Other: AI model biased against COPD Sponsors: University of Michigan; National Heart, Lung, and Blood Institute (NHLBI) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Veterans Affairs Pharmacist Heart Failure Medication Titration Project 1
Conditions: Heart Failure Interventions: Other: Audit and Feedback Emails; Other: Patient Specific Targets; Other: Educational Resources Sponsors: Stanford University; VA Palo Alto Health Care System Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes
Conditions: Heart Failure Interventions: Other: HeartLogic Sponsors: Tor Biering-S ørensen; Boston Scientific Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Heart Failure Treatment Pattern Analysis of HF Patients in HF Centers and Non-HF Centers in China
Conditions: Heart Failure Interventions: Other: no intervention Sponsors: Peking University First Hospital; China Cardiovascular Association; AstraZeneca Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Gliflozins on HF in Regurgitant Rheumatic Heart
Conditions: Rheumatic Heart Disease; Heart Failure Interventions: Drug: SGLT2 inhibitor Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Narrative Intervention for Chronic Illness
Conditions: Heart Failure; Heart Failure NYHA Class III; Heart Failure NYHA Class IV Interventions: Behavioral: Narrative Intervention for Chronic Illness-Heart Failure Sponsors: University of Colorado, Denver Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients
Conditions: Heart Failure Acute Interventions: Other: Urine sodium guided diuretic algorithm; Other: Usual care Sponsors: Zuyderland Medisch Centrum Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Conditions: Cancer; Heart Failure; Arrhythmia; Doxorubicin Induced Cardiomyopathy; Doxorubicin Adverse Reaction Interventions: Drug: Control group:DH001 placebo; Drug: Trial group: DH001 low-dose group; Drug: Trial group: DH001 high-dose group Sponsors: Monyan Pharmaceutical (Shanghai) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
